Next Article in Journal
Design and Characterization of a New Formulation for the Delivery of COVID-19-mRNA Vaccine to the Nasal Mucosa
Previous Article in Journal
Distinct Adverse Reactions to mRNA, Inactivated Virus, and Adenovirus Vector COVID-19 Vaccines: Insights from a Cohort Study on Atopic and Non-Atopic Subjects in Brazil
Previous Article in Special Issue
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human Primate Model
 
 
Article

Article Versions Notes

Vaccines 2024, 12(4), 410; https://doi.org/10.3390/vaccines12040410
Action Date Notes Link
article xml file uploaded 12 April 2024 11:40 CEST Original file -
article xml uploaded. 12 April 2024 11:40 CEST Update -
article pdf uploaded. 12 April 2024 11:40 CEST Version of Record https://www.mdpi.com/2076-393X/12/4/410/pdf-vor
article html file updated 12 April 2024 11:42 CEST Original file -
article xml file uploaded 15 April 2024 07:32 CEST Update -
article xml uploaded. 15 April 2024 07:32 CEST Update -
article pdf uploaded. 15 April 2024 07:32 CEST Updated version of record https://www.mdpi.com/2076-393X/12/4/410/pdf-vor
article html file updated 15 April 2024 07:35 CEST Update -
article xml file uploaded 15 April 2024 14:33 CEST Update -
article xml uploaded. 15 April 2024 14:33 CEST Update https://www.mdpi.com/2076-393X/12/4/410/xml
article pdf uploaded. 15 April 2024 14:33 CEST Updated version of record https://www.mdpi.com/2076-393X/12/4/410/pdf
article html file updated 15 April 2024 14:35 CEST Update https://www.mdpi.com/2076-393X/12/4/410/html
Back to TopTop